Ryerson (NYSE: RYI) CAO awarded new RSU dividend equivalents

Rhea-AI Filing Summary

Kannan Molly D reported acquisition or exercise transactions in this Form 4 filing.

Ryerson Holding Corp reported that CAO & Corporate Controller Molly D. Kannan received three small awards of restricted stock units on March 19, 2026. The grants cover 19.457, 38.058, and 62.959 dividend-equivalent RSUs, each representing the right to one share of common stock. These dividend equivalents accrue as the company pays dividends and will vest on the same schedules as the underlying RSU grants from 2023, 2024, and 2025, with vesting dates running through March 31, 2028. Following these awards, Kannan holds 6,825.550 restricted stock units directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kannan Molly D

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CAO & Corporate Controller

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/19/2026		A		19.457(2)		(3)	(3)	Common Stock	19.457	$0	2,109.309	D
Restricted Stock Units	(1)	03/19/2026		A		38.058(2)		(4)	(4)	Common Stock	38.058	$0	4,125.959	D
Restricted Stock Units	(1)	03/19/2026		A		62.959(2)		(5)	(5)	Common Stock	62.959	$0	6,825.55	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026.

4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027.

5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028.

	/s/ Camilla Rykke Merrick, attorney-in-fact	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Ryerson (RYI) report for Molly D. Kannan?

Ryerson reported RSU grants to CAO & Corporate Controller Molly D. Kannan. She received three awards of dividend-equivalent restricted stock units on March 19, 2026, tied to prior RSU grants from 2023, 2024, and 2025, with future vesting dates.

How many restricted stock units did the Ryerson (RYI) CAO receive?

The filing shows three RSU awards: 19.457, 38.058, and 62.959 dividend-equivalent restricted stock units. Each unit represents a contingent right to receive one share of Ryerson common stock, subject to vesting on the same schedule as the underlying RSU grants.

What are dividend-equivalent rights in the Ryerson (RYI) Form 4 filing?

Dividend-equivalent rights mirror cash dividends on underlying RSUs. They accrue when Ryerson pays dividends on its common shares and convert into additional RSUs. These new units vest, settle, and expire on the same terms and timing as the original restricted stock unit awards.

When will the reported Ryerson (RYI) RSU dividend equivalents vest?

The vesting follows the original RSU grants. Dividend-equivalent RSUs tied to 2023 awards vest March 31, 2026; those tied to 2024 awards vest March 31, 2026 and March 31, 2027; and those tied to 2025 awards vest March 31, 2026, 2027, and 2028.

How many restricted stock units does the Ryerson (RYI) CAO hold after these grants?

Post-transaction, the filing shows 6,825.550 RSUs directly held by Molly D. Kannan. Each restricted stock unit represents a contingent right to receive one Ryerson common share, subject to the applicable vesting and settlement terms described in the awards.

Do the Ryerson (RYI) RSU dividend equivalents involve any stock sales?

No stock sales are reported in this Form 4. All three transactions are coded as grants or awards (code A), reflecting additional restricted stock units credited as dividend equivalents rather than open-market purchases or sales of Ryerson common stock.